+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Platelet hyperactivity after statin treatment discontinuation



Platelet hyperactivity after statin treatment discontinuation



Thrombosis and Haemostasis 90(3): 476-482



Hydroxymethyl-glutaryl-CoA-reductase inhibitors (statins) reduce cardiovascular events by cholesterol lowering as well as by non-lipid related actions. Among them, the modulation of platelet activity could play a relevant role in vascular protection. Furthermore withdrawal of statins has been associated with increased cardiovascular event rate. The aim of our study was to evaluate platelet activity after cerivastatin discontinuation in eighteen subjects that did not accept other drugs and in sixteen subjects continuing treatment with simvastatin. Fourteen subjects at the end of the discontinuation period decided to receive other drugs (simvastatin) and they were evaluted six weeks later. We measured complete lipid profile by the chromogenic method (LDL-C was calculated); oxidized-LDL (ox-LDL; ELISA), platelet P-selectin (P-sel) expression (flow cytometry detection), platelet aggregation (% change of transmitted light), intracellular citrullin production (iCit; HPLC) as an indicator of intracellular NO synthase activity at baseline and 7, 14, 28, 60 days after statin discontinuation. P-sel expression and platelet aggregation were increased at 14 days (p < 0.001 and p < 0.05) in association with raised ox-LDL (r = 0.30, p < 0.05) and decreased iCit (r = 0.53, p < 0.01). Increased LDL-C was related to P-sel and platelet aggregation at 28 days (r = 0.30, p < 0.05). Subjects continuing statin treatment had no significant changes of P-sel at 28 (p = 0.221) and 60 days (p = 0.238). Subjects treated with simvastatin after 60 days of diet showed a significant reduction of P-sel and platelet aggregation after six weeks of treatment (p < 0.01). Our data suggest a platelet hyperactivation state in the second week after statin discontinuation which is partially related to raised LDL-C. Such a finding could participate in the increased cardiovascular event rate after statin discontinuation.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 011161019

Download citation: RISBibTeXText

PMID: 12958617

DOI: 10.1160/th03-02-0111


Related references

Patient characteristics and statin discontinuation-related factors during treatment of hypercholesterolemia: an observational non-interventional study in patients with statin discontinuation (STAY study). Turk Kardiyoloji Dernegi Arsivi 44(1): 53-64, 2016

Treatment of statin adverse effects with supplemental Coenzyme Q(10) and statin drug discontinuation. Biofactors 25(1-4): 147-152, 2005

Treatment of statin adverse effects with supplemental Coenzyme Q10 and statin drug discontinuation. Biofactors 25(1-4): 147-152, 2005

Ability of low antihypertensive medication adherence to predict statin discontinuation and low statin adherence in patients initiating treatment after a coronary event. American Journal of Cardiology 114(6): 826-831, 2014

Discontinuation of statin treatment in stroke patients. Stroke 37(10): 2640-2643, 2006

Predictors of Statin Adherence, Switching, and Discontinuation in the USAGE Survey Understanding Statin Use in America and Gaps in Patient Education. Journal of Clinical Lipidology 7(3): 245-246, 2013

Accelerated platelet inhibition by switching from atorvastatin to a non-CYP3A4-metabolized statin in patients with high platelet reactivity (ACCEL-STATIN) study. European Heart Journal 33(17): 2151-2162, 2013

Statin treatment non-adherence and discontinuation: clinical implications and potential solutions. Current Pharmaceutical Design 20(40): 6314-6324, 2014

Discontinuation and restarting in patients on statin treatment: prospective open cohort study using a primary care database. Bmj 353: I3305, 2016

Attention-deficit hyperactivity disorder: treatment discontinuation in adolescents and young adults. British Journal of Psychiatry 194(3): 273-277, 2009

Exploratory analysis of early treatment discontinuation and clinical outcomes of patients with attention-deficit/hyperactivity disorder. Asia-PacificPsychiatry9(1):, 2017

Treatment discontinuation with methylphenidate in adults with attention deficit hyperactivity disorder: a meta-analysis of randomized clinical trials. European Journal of Clinical Pharmacology 69(3): 347-356, 2013

Chinese red rice depletes muscle coenzyme Q10 and maintains muscle damage after discontinuation of statin treatment. Journal of the American Geriatrics Society 54(4): 718-720, 2006

Influence of statin treatment on platelet inhibition by clopidogrel - a randomized comparison of rosuvastatin, atorvastatin and simvastatin co-treatment. Journal of Internal Medicine 266(5): 457-466, 2009

Abnormally high platelet activity after discontinuation of acetylsalicylic acid treatment. Blood Coagulation & Fibrinolysis 7(1): 80-84, 1996